Correlation Between Aclarion and Mangoceuticals, Common
Can any of the company-specific risk be diversified away by investing in both Aclarion and Mangoceuticals, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclarion and Mangoceuticals, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aclarion and Mangoceuticals, Common Stock, you can compare the effects of market volatilities on Aclarion and Mangoceuticals, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclarion with a short position of Mangoceuticals, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclarion and Mangoceuticals, Common.
Diversification Opportunities for Aclarion and Mangoceuticals, Common
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Aclarion and Mangoceuticals, is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Aclarion and Mangoceuticals, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangoceuticals, Common and Aclarion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclarion are associated (or correlated) with Mangoceuticals, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangoceuticals, Common has no effect on the direction of Aclarion i.e., Aclarion and Mangoceuticals, Common go up and down completely randomly.
Pair Corralation between Aclarion and Mangoceuticals, Common
Assuming the 90 days horizon Aclarion is expected to generate 29.01 times more return on investment than Mangoceuticals, Common. However, Aclarion is 29.01 times more volatile than Mangoceuticals, Common Stock. It trades about 0.15 of its potential returns per unit of risk. Mangoceuticals, Common Stock is currently generating about -0.12 per unit of risk. If you would invest 3.19 in Aclarion on September 4, 2024 and sell it today you would earn a total of 0.71 from holding Aclarion or generate 22.26% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 62.5% |
Values | Daily Returns |
Aclarion vs. Mangoceuticals, Common Stock
Performance |
Timeline |
Aclarion |
Mangoceuticals, Common |
Aclarion and Mangoceuticals, Common Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aclarion and Mangoceuticals, Common
The main advantage of trading using opposite Aclarion and Mangoceuticals, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclarion position performs unexpectedly, Mangoceuticals, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangoceuticals, Common will offset losses from the drop in Mangoceuticals, Common's long position.Aclarion vs. Aclarion | Aclarion vs. Iveda Solutions Warrant | Aclarion vs. Heartbeam Warrant | Aclarion vs. Edible Garden AG |
Mangoceuticals, Common vs. FOXO Technologies | Mangoceuticals, Common vs. Healthcare Triangle | Mangoceuticals, Common vs. Bullfrog AI Holdings, | Mangoceuticals, Common vs. EUDA Health Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |